INTEGRIN ASSOCIATED PROTEIN/CD47 IS A THROMBOSPONDIN RECEPTOR

整合素相关蛋白/CD47 是一种血小板反应蛋白受体

基本信息

  • 批准号:
    8288113
  • 负责人:
  • 金额:
    $ 37.62万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2002
  • 资助国家:
    美国
  • 起止时间:
    2002-07-01 至 2014-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Thrombospondin-1 (TSP1) and its receptors have long been thought to have important roles in regulating vascular cells, both circulating and mural. During the preceding grant period we have discovered that TSP1 and CD47 (integrin-associated protein) regulate the dynamic range of nitric oxide (NO) signaling in vascular cells. Thus TSP1-CD47 interactions are important not only in angiogenic regulation but in rapid regulation of tissue perfusion and many other roles where NO maintains the health of the cardiovascular system. We have identified the binding surface on the C-terminal domain of TSP1 that interacts with CD47. We have also discovered a new extracellular mechanism for integrin activation via CD47. This proposal focuses on the molecular interactions among TSP1, CD47 and 23 integrins. The molecular details of these interactions will be deduced by mutagenesis of all three interacting partners. Mutant proteins will be tested in vitro in binding assays and assays of CD47 and integrin function. The extracellular clasp mechanism for integrin activation that we identified within the 1v23 structure will be tested in cultured cells and in 23-null mice repopulated with bone marrow expressing activated 23 integrin constructs. A similar approach will test the ability of CD47 to activate 23 integrins via interaction with the clasp in cultured cells and in mice expressing mutant CD47 transgenes. Conditions for formation of TSP1-CD47 and CD47-integrin complexes will be evaluated using physical methods and several EM approaches. These methods will then be used to evaluate the interactions of mutant proteins in order to identify structural elements of each that are important for their molecular interactions. Based on these results, crystallization and X-ray diffraction studies will be initiated of CD47 in complexes with the TSP1 C-terminal domain and with 1v23 integrin. The sum of these studies will provide for the first time a physical model of TSP1-CD47-integrin interactions. Given our new paradigm for TSP1-CD47 regulation of NO signaling in the vascular system, this information will be vital in designing new strategies to modulate endogenous NO signaling, a new approach to ameliorating cardiovascular disease.
描述(申请人提供):血栓反应蛋白-1(TSP1)及其受体长期以来一直被认为在调节循环和壁上的血管细胞方面具有重要作用。在前面的授权期,我们发现TSP1和CD47(整合素相关蛋白)调节血管细胞中一氧化氮(NO)信号的动态范围。因此,TSP1-CD47的相互作用不仅在血管生成调节中,而且在组织灌流的快速调节以及在NO维持心血管系统健康的许多其他作用中都是重要的。我们已经确定了TSP1的C-末端结构域上与CD47相互作用的结合面。我们还发现了一种通过CD47激活整合素的新的细胞外机制。本研究的重点是TSP1、CD47和23整合素之间的分子相互作用。这些相互作用的分子细节将通过所有三个相互作用伙伴的突变来推断。突变蛋白将在体外进行结合试验和CD47和整合素功能的试验。我们在1v23结构中确定的整合素激活的细胞外扣机制将在培养细胞和重新填充表达激活的23整合素结构的骨髓的23缺失小鼠中进行测试。类似的方法将在培养细胞和表达突变CD47转基因的小鼠中测试CD47通过与CLAP相互作用激活23整合素的能力。TSP1-CD47和CD47-整合素复合体的形成条件将使用物理方法和几种EM方法进行评估。然后这些方法将被用来评估突变蛋白质的相互作用,以确定每种蛋白质的结构元素对它们的分子相互作用是重要的。在这些结果的基础上,将开始CD47在与TSP1 C-末端结构域和与1v23整合素的复合物中的结晶和X射线衍射研究。这些研究的总和将首次提供TSP1-CD47-整合素相互作用的物理模型。鉴于我们对血管系统中NO信号的TSP1-CD47调节的新范式,这些信息对于设计新的策略来调节内源性NO信号将是至关重要的,这是一种改善心血管疾病的新方法。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A naturally occurring extracellular alpha-beta clasp contributes to stabilization of beta3 integrins in a bent, resting conformation.
  • DOI:
    10.1021/bi8015108
  • 发表时间:
    2008-10
  • 期刊:
  • 影响因子:
    2.9
  • 作者:
    Anthony N. Vomund;S. Stuhlsatz-Krouper;J. Dimitry;Yuhua Song;W. Frazier
  • 通讯作者:
    Anthony N. Vomund;S. Stuhlsatz-Krouper;J. Dimitry;Yuhua Song;W. Frazier
Age-dependent regulation of skeletal muscle mitochondria by the thrombospondin-1 receptor CD47.
  • DOI:
    10.1016/j.matbio.2010.12.004
  • 发表时间:
    2011-03
  • 期刊:
  • 影响因子:
    6.9
  • 作者:
    Frazier, Elfaridah P.;Isenberg, Jeff S.;Shiva, Sruti;Zhao, Lei;Schlesinger, Paul;Dimitry, Julie;Abu-Asab, Mones S.;Tsokos, Maria;Roberts, David D.;Frazier, William A.
  • 通讯作者:
    Frazier, William A.
Distortion of the catalytic domain of tissue-type plasminogen activator by plasminogen activator inhibitor-1 coincides with the formation of stable serpin-proteinase complexes.
纤溶酶原激活剂抑制剂-1对组织型纤溶酶原激活剂催化结构域的扭曲与稳定的丝氨酸蛋白酶抑制剂-蛋白酶复合物的形成同时发生。
  • DOI:
    10.1074/jbc.m306184200
  • 发表时间:
    2003
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Perron,MichelJ;Blouse,GrantE;Shore,JosephD
  • 通讯作者:
    Shore,JosephD
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

WILLIAM A FRAZIER其他文献

WILLIAM A FRAZIER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('WILLIAM A FRAZIER', 18)}}的其他基金

Tumor-toxic CD47 mAb therapy for leukemia: a proof of concept study
肿瘤毒性 CD47 mAb 治疗白血病:概念验证研究
  • 批准号:
    8520948
  • 财政年份:
    2013
  • 资助金额:
    $ 37.62万
  • 项目类别:
Development of a humanized anti-CD47 antibody for treatment of tissue ischemia.
开发用于治疗组织缺血的人源化抗 CD47 抗体。
  • 批准号:
    7669899
  • 财政年份:
    2009
  • 资助金额:
    $ 37.62万
  • 项目类别:
Integrin Associated Protein in a Thrombospondin Receptor
血小板反应蛋白受体中的整合素相关蛋白
  • 批准号:
    6752865
  • 财政年份:
    2002
  • 资助金额:
    $ 37.62万
  • 项目类别:
Integrin Associated Protein in a Thrombospondin Receptor
血小板反应蛋白受体中的整合素相关蛋白
  • 批准号:
    7418842
  • 财政年份:
    2002
  • 资助金额:
    $ 37.62万
  • 项目类别:
INTEGRIN ASSOCIATED PROTEIN/CD47 IS A THROMBOSPONDIN RECEPTOR
整合素相关蛋白/CD47 是一种血小板反应蛋白受体
  • 批准号:
    7622611
  • 财政年份:
    2002
  • 资助金额:
    $ 37.62万
  • 项目类别:
INTEGRIN ASSOCIATED PROTEIN/CD47 IS A THROMBOSPONDIN RECEPTOR
整合素相关蛋白/CD47 是一种血小板反应蛋白受体
  • 批准号:
    7370079
  • 财政年份:
    2002
  • 资助金额:
    $ 37.62万
  • 项目类别:
INTEGRIN ASSOCIATED PROTEIN/CD47 IS A THROMBOSPONDIN RECEPTOR
整合素相关蛋白/CD47 是一种血小板反应蛋白受体
  • 批准号:
    7883168
  • 财政年份:
    2002
  • 资助金额:
    $ 37.62万
  • 项目类别:
Integrin Associated Protein in a Thrombospondin Receptor
血小板反应蛋白受体中的整合素相关蛋白
  • 批准号:
    6901007
  • 财政年份:
    2002
  • 资助金额:
    $ 37.62万
  • 项目类别:
INTEGRIN ASSOCIATED PROTEIN/CD47 IS A THROMBOSPONDIN RECEPTOR
整合素相关蛋白/CD47 是一种血小板反应蛋白受体
  • 批准号:
    8100483
  • 财政年份:
    2002
  • 资助金额:
    $ 37.62万
  • 项目类别:
Integrin Associated Protein in a Thrombospondin Receptor
血小板反应蛋白受体中的整合素相关蛋白
  • 批准号:
    6547705
  • 财政年份:
    2002
  • 资助金额:
    $ 37.62万
  • 项目类别:

相似海外基金

RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
  • 批准号:
    2327346
  • 财政年份:
    2024
  • 资助金额:
    $ 37.62万
  • 项目类别:
    Standard Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
  • 批准号:
    2312555
  • 财政年份:
    2024
  • 资助金额:
    $ 37.62万
  • 项目类别:
    Standard Grant
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
  • 批准号:
    BB/Z514391/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.62万
  • 项目类别:
    Training Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
  • 批准号:
    ES/Z502595/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.62万
  • 项目类别:
    Fellowship
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
  • 批准号:
    ES/Z000149/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.62万
  • 项目类别:
    Research Grant
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
  • 批准号:
    23K24936
  • 财政年份:
    2024
  • 资助金额:
    $ 37.62万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
  • 批准号:
    2901648
  • 财政年份:
    2024
  • 资助金额:
    $ 37.62万
  • 项目类别:
    Studentship
ERI: Developing a Trust-supporting Design Framework with Affect for Human-AI Collaboration
ERI:开发一个支持信任的设计框架,影响人类与人工智能的协作
  • 批准号:
    2301846
  • 财政年份:
    2023
  • 资助金额:
    $ 37.62万
  • 项目类别:
    Standard Grant
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
  • 批准号:
    488039
  • 财政年份:
    2023
  • 资助金额:
    $ 37.62万
  • 项目类别:
    Operating Grants
How motor impairments due to neurodegenerative diseases affect masticatory movements
神经退行性疾病引起的运动障碍如何影响咀嚼运动
  • 批准号:
    23K16076
  • 财政年份:
    2023
  • 资助金额:
    $ 37.62万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了